 | • レポートコード：MRC2304A006 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、257ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に262.7億ドルであった世界の在宅医療市場規模が2022年に284.3億ドルへと拡大、更に2027年までにCAGR 8.38％で成長して426.0億ドルに達すると予測しています。当書は、在宅医療の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、コンポーネント別分析（サービス、ソリューション）、製品別分析（在宅医療モビリティケア製品、検査・スクリーニング・モニタリング製品、治療用製品）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの構成でまとめています。なお、当書には、A&D Company, Limited、Abbott Laboratories、Amedisys, Inc.、Apex Medical Corp.、Bayada Home Health Care、Caremax Rehabilitation Equipment Co., Ltd.、Contec Medical Systems Co., Ltd.、Drive Devilbiss Healthcare、F. Hoffmann-La Roche AG、Fresenius Medical Care AG & Co. KGaAなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の在宅医療市場規模：コンポーネント別 - 在宅医療サービスの市場規模 - 在宅医療ソリューションの市場規模 ・世界の在宅医療市場規模：製品別 - 在宅医療モビリティケア製品の市場規模 - 検査・スクリーニング・モニタリング製品の市場規模 - 治療用製品の市場規模 ・世界の在宅医療市場規模：地域別 - 南北アメリカの在宅医療市場規模 アメリカの在宅医療市場規模 カナダの在宅医療市場規模 ブラジルの在宅医療市場規模 ... - アジア太平洋の在宅医療市場規模 日本の在宅医療市場規模 中国の在宅医療市場規模 インドの在宅医療市場規模 韓国の在宅医療市場規模 台湾の在宅医療市場規模 ... - ヨーロッパ/中東/アフリカの在宅医療市場規模 イギリスの在宅医療市場規模 ドイツの在宅医療市場規模 フランスの在宅医療市場規模 ロシアの在宅医療市場規模 ... - その他地域の在宅医療市場規模 ・競争状況 ・企業情報 |
The Global Home Healthcare Market size was estimated at USD 26.27 billion in 2021 and expected to reach USD 28.43 billion in 2022, and is projected to grow at a CAGR 8.38% to reach USD 42.60 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Home Healthcare to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Component, the market was studied across Services and Solution. The Services is further studied across Hospice & Palliative Care Services, Infusion Therapy Services, Pregnancy Care Services, Rehabilitation Therapy Services, Respiratory Therapy Services, Skilled Nursing Services, and Unskilled Care Services. The Solution is further studied across Agency Software, Clinical Management Systems, Hospice Solutions, and Telehealthcare Solutions.
Based on Product, the market was studied across Home Healthcare Mobility Care Products, Testing, Screening, & Monitoring Products, and Therapeutic Products. The Home Healthcare Mobility Care Products is further studied across Canes, Crutches, Mobility Scooters, Walkers & Rollators, and Wheelchairs. The Testing, Screening, & Monitoring Products is further studied across Blood Glucose Monitors, Blood Pressure Monitors, Drug & Alcohol Test Kits, ECG/EKG Devices, EEG Devices, Heart Rate Monitors, HIV Test Kits, Ovulation & Pregnancy Test Kits, Pedometers & Pulse Oximeters, Sleep Apnea Monitors, and Temperature Monitors. The Therapeutic Products is further studied across Dialysis Equipment, Inhalers, Insulin Delivery Devices, IV Equipment, Nebulizers, Oxygen Delivery Systems, Sleep Apnea Therapeutic Devices, Ventilators, and Wound Care Products.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Home Healthcare market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Home Healthcare Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Home Healthcare Market, including A&D Company, Limited, Abbott Laboratories, Amedisys, Inc., Apex Medical Corp., Bayada Home Health Care, Caremax Rehabilitation Equipment Co., Ltd., Contec Medical Systems Co., Ltd., Drive Devilbiss Healthcare, F. Hoffmann-La Roche AG, Fresenius Medical Care AG & Co. KGaA, GE Healthcare, Hamilton Medical AG, Invacare Corporation, Kindred Healthcare, LLC, Koninklijke Philips N.V., LHC Group, Inc., Linde PLC, Löwenstein Medical Technology GmbH + Co. KG., Omron Corporation, RENAFAN GmbH, Roma Medical Aids Limited, Sunrise Medical, Inc., and Vitalograph Limited.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Home Healthcare Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Home Healthcare Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Home Healthcare Market?
4. What is the competitive strategic window for opportunities in the Global Home Healthcare Market?
5. What are the technology trends and regulatory frameworks in the Global Home Healthcare Market?
6. What is the market share of the leading vendors in the Global Home Healthcare Market?
7. What modes and strategic moves are considered suitable for entering the Global Home Healthcare Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Healthcare Costs
5.1.1.2. Technology Advancements in Home-Aided Healthcare
5.1.1.3. Government Initiatives Promoting Home Healthcare
5.1.2. Restraints
5.1.2.1. Limitation Associated with the Insurance Coverage and the Reimbursement Policies
5.1.3. Opportunities
5.1.3.1. Rising Adoption of Telemedicine and Telehealth
5.1.3.2. Emerging Home Healthcare Services in the Developing Economies
5.1.4. Challenges
5.1.4.1. Limited Availability of Home Care Workers
5.2. Cumulative Impact of COVID-19
6. Home Healthcare Market, by Component
6.1. Introduction
6.2. Services
6.3.1. Hospice & Palliative Care Services
6.3.2. Infusion Therapy Services
6.3.3. Pregnancy Care Services
6.3.4. Rehabilitation Therapy Services
6.3.5. Respiratory Therapy Services
6.3.6. Skilled Nursing Services
6.3.7. Unskilled Care Services
6.3. Solution
6.4.1. Agency Software
6.4.2. Clinical Management Systems
6.4.3. Hospice Solutions
6.4.4. Telehealthcare Solutions
7. Home Healthcare Market, by Product
7.1. Introduction
7.2. Home Healthcare Mobility Care Products
7.3.1. Canes
7.3.2. Crutches
7.3.3. Mobility Scooters
7.3.4. Walkers & Rollators
7.3.5. Wheelchairs
7.3. Testing, Screening, & Monitoring Products
7.4.1. Blood Glucose Monitors
7.4.2. Blood Pressure Monitors
7.4.3. Drug & Alcohol Test Kits
7.4.4. ECG/EKG Devices
7.4.5. EEG Devices
7.4.6. Heart Rate Monitors
7.4.7. HIV Test Kits
7.4.8. Ovulation & Pregnancy Test Kits
7.4.9. Pedometers & Pulse Oximeters
7.4.10. Sleep Apnea Monitors
7.4.11. Temperature Monitors
7.4. Therapeutic Products
7.5.1. Dialysis Equipment
7.5.2. Inhalers
7.5.3. Insulin Delivery Devices
7.5.4. IV Equipment
7.5.5. Nebulizers
7.5.6. Oxygen Delivery Systems
7.5.7. Sleep Apnea Therapeutic Devices
7.5.8. Ventilators
7.5.9. Wound Care Products
8. Americas Home Healthcare Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Home Healthcare Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Home Healthcare Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. A&D Company, Limited
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Abbott Laboratories
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Amedisys, Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Apex Medical Corp.
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Bayada Home Health Care
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Caremax Rehabilitation Equipment Co., Ltd.
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Contec Medical Systems Co., Ltd.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Drive Devilbiss Healthcare
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. F. Hoffmann-La Roche AG
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Fresenius Medical Care AG & Co. KGaA
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. GE Healthcare
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Hamilton Medical AG
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Invacare Corporation
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Kindred Healthcare, LLC
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Koninklijke Philips N.V.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. LHC Group, Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Linde PLC
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Löwenstein Medical Technology GmbH + Co. KG.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Omron Corporation
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. RENAFAN GmbH
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Roma Medical Aids Limited
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Sunrise Medical, Inc.
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Vitalograph Limited
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing